batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Enhertu's next step to breast cancer domination 7 May 2025 Mersana goes all in on B7-H4 6 May 2025 Janux loses some shine 6 May 2025 Anktiva gets a papillary knockback 6 May 2025 Up next for saci-T is a challenge to Jemperli 2 May 2025 GSK hatches pivotal Hansoh conjugate plans 30 April 2025 AACR 2025 – Senti fails to impress 29 April 2025 AACR 2025 – Roche sets a bar in Werner helicase inhibition 29 April 2025 Load More